Skip to main navigation Skip to search Skip to main content

Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial

  • Romualdo Barroso-Sousa
  • , Paolo Tarantino
  • , Nabihah Tayob
  • , Chau Dang
  • , Denise A. Yardley
  • , Steven J. Isakoff
  • , Vicente Valero
  • , Meredith Faggen
  • , Therese Mulvey
  • , Ron Bose
  • , Jiani Hu
  • , Douglas Weckstein
  • , Antonio C. Wolff
  • , Katherine Reeder-Hayes
  • , Hope S. Rugo
  • , Bhuvaneswari Ramaswamy
  • , Dan Zuckerman
  • , Lowell Hart
  • , Vijayakrishna K. Gadi
  • , Michael Constantine
    • Kit Cheng, Frederick Briccetti, Bryan Schneider, Audrey Merrill Garrett, Kelly Marcom, Kathy Albain, Patricia DeFusco, Nadine Tung, Blair Ardman, Rita Nanda, Rachel C. Jankowitz, Mothaffar Rimawi, Vandana Abramson, Paula R. Pohlmann, Catherine Van Poznak, Andres Forero-Torres, Minetta Liu, Kathryn J. Ruddy, Yue Zheng, Shoshana M. Rosenberg, Richard D. Gelber, Lorenzo Trippa, William Barry, Michelle DeMeo, Harold Burstein, Ann Partridge, Eric P. Winer, Ian Krop, Sara M. Tolaney

Research output: Contribution to journal › Article › peer-review

12   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology